The FDA has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension,...
Neos Therapeutics has resubmitted a New Drug Application to the FDA for its amphetamine XR orally disintegrating tablet product candidate,...